國家衛生研究院 NHRI:Item 3990099045/9236
English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 12145/12927 (94%)
造訪人次 : 855279      線上人數 : 1034
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧：
  • 您可在西文檢索詞彙前後加上"雙引號"，以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋，建議至進階搜尋限定作者欄位，可獲得較完整資料
    •  進階搜尋
    主頁 ‧ 登入 ‧ 上傳 ‧ 說明 ‧ 關於NHRI ‧ 管理 到手機版


    請使用永久網址來引用或連結此文件: http://ir.nhri.org.tw/handle/3990099045/9236


    題名: Akt3 promotes prostate cancer proliferation cells through regulation of Akt, B-Raf & TSC1/TSC2
    作者: Lin, HP;Lin, CY;Huo, C;Jan, YJ;Tseng, JC;Jiang, SS;Kuo, YY;Chen, SC;Wang, CT;Chan, TM;Liou, JY;Wang, J;Chang, WW;Chang, CH;Kung, HJ;Chuu, CP
    貢獻者: Institute of Molecular and Genomic Medicine;National Institute of Cancer Research;Institute of Cellular and Systems Medicine
    摘要: The qRT-PCR analysis of 139 clinical samples and analysis of 150 on-line database clinical samples indicated that AKT3 mRNA expression level was elevated in primary prostate tumors. Immunohistochemical staining of 65 clinical samples revealed that AKT3 protein expression was higher in prostate tumors of stage I, II, III as compared to nearby normal tissues. Plasmid overexpression of AKT3 promoted cell proliferation of LNCaP, PC-3, DU-145, and CA-HPV-10 human prostate cancer (PCa) cells, while knockdown of AKT3 by siRNA reduced cell proliferation. Overexpression of AKT3 increased the protein expression of total AKT, phospho-AKT S473, phospho-AKT T308, B-Raf, c-Myc, Skp2, cyclin E, GSK3beta, phospho-GSK3beta S9, phospho-mTOR S2448, and phospho-p70S6K T421/S424, but decreased TSC1 (tuberous sclerosis 1) and TSC2 (tuberous Sclerosis Complex 2) proteins in PC-3 PCa cells. Overexpression of AKT3 also increased protein abundance of phospho-AKT S473, phospho-AKT T308, and B-Raf but decreased expression of TSC1 and TSC2 proteins in LNCaP, DU-145, and CA-HPV-10 PCa cells. Oncomine datasets analysis suggested that AKT3 mRNA level was positively correlated to BRAF. Knockdown of AKT3 in DU-145 cells with siRNA increased the sensitivity of DU-145 cells to B-Raf inhibitor treatment. Knockdown of TSC1 or TSC2 promoted the proliferation of PCa cells. Our observations implied that AKT3 may be a potential therapeutic target for PCa treatment.
    日期: 2015-07-10
    關聯: Oncotarget. 2015 Jul 10;6(29):27097-27112.
    Link to: http://dx.doi.org/10.18632/oncotarget.4553
    Cited Times(WOS): https://www.webofscience.com/wos/woscc/full-record/WOS:000363161300051
    Cited Times(Scopus): http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=84944472711
    顯示於類別:[龔行健] 期刊論文
    [張文祥] 期刊論文
    [江士昇] 期刊論文
    [褚志斌] 期刊論文
    [張中和] 期刊論文
    [劉俊揚] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    PUB26318033.pdf2309KbAdobe PDF712檢視/開啟


    在NHRI中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋